Evidence map›Paper›PMID 37102678›Full record

ArticleAnalytical chemistry2023

Membrane Protein Binding Interactions Studied in Live Cells via Diethylpyrocarbonate Covalent Labeling Mass Spectrometry.

Zachary J Kirsch, Jeanna M Blake, Uyen Huynh, Dheeraj K Agrohia, Catherine Y Tremblay, Eric M Graban, Robert C Vaughan, Richard W Vachet

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Precursor Reagent Hydrophobicity Affects Membrane Protein Footprinting.Journal of the American Society for Mass Spectrometry · 2023
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zachary J KirschDepartment of Chemistry, University of Massachusetts, Amherst, Massachusetts 01003, United States.ORCID 0000-0001-7788-6223
Jeanna M BlakeQuarryBio, Collins Building, 2051 East Paul Dirac Drive, Tallahassee, Florida 32310, United States.
Uyen HuynhDepartment of Chemistry, University of Massachusetts, Amherst, Massachusetts 01003, United States.
Dheeraj K AgrohiaDepartment of Chemistry, University of Massachusetts, Amherst, Massachusetts 01003, United States.
Catherine Y TremblayDepartment of Chemistry, University of Massachusetts, Amherst, Massachusetts 01003, United States.
Eric M GrabanQuarryBio, Collins Building, 2051 East Paul Dirac Drive, Tallahassee, Florida 32310, United States.
Robert C VaughanQuarryBio, Collins Building, 2051 East Paul Dirac Drive, Tallahassee, Florida 32310, United States.
Richard W VachetDepartment of Chemistry, University of Massachusetts, Amherst, Massachusetts 01003, United States.ORCID 0000-0003-4514-0210
University of Massachusetts Amherst · US

Funding

CHEMISTRY-BIOLOGY INTERFACE PREDOCTORAL TRAINING GRANTST32GM008515 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI THOMPSON, LYNMARIE K. · 1995 to 2020
$4.3M
Copper-Induced Amyloidosis Studied by Mass SpectrometryR01GM075092 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI VACHET, RICHARD W · 2005 to 2020
$4.0M
Chemistry-Biology Interface Predoctoral Training GrantT32GM139789 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI ERIC Robert STRIETER · 2021 to 2026
$3.4M
Protein Amyloid Formation and Inhibition Studied by Mass SpectrometryR35GM145272 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI RICHARD W VACHET · 2022 to 2026
$2.0M
Acquisition of an Orbitrap MSS10OD010645 · OD · UNIVERSITY OF MASSACHUSETTS AMHERST · PI EYLES, STEPHEN J. · 2013 to 2013
$600k
Higher Order Structure Analysis of Protein Therapeutics by Covalent Labeling MSR43GM116211 · NIGMS · RECLAIM PHARMACEUTICAL WASTE MANAGEMENT · PI GRABAN, ERIC · 2016 to 2016
$277k
NIGMS NIH HHS R01 GM075092NIGMS NIH HHS R35 GM145272NIGMS NIH HHS R43 GM116211NIGMS NIH HHS T32 GM008515NIGMS NIH HHS T32 GM139789NIH HHS S10 OD010645
6 · The paper itself

Abstract

Membrane proteins are vital in the human proteome for their cellular functions and make up a majority of drug targets in the U.S. However, characterizing their higher-order structures and interactions remains challenging. Most often membrane proteins are studied in artificial membranes, but such artificial systems do not fully account for the diversity of components present in cell membranes. In this study, we demonstrate that diethylpyrocarbonate (DEPC) covalent labeling mass spectrometry can provide binding site information for membrane proteins in living cells using membrane-bound tumor necrosis factor α (mTNFα) as a model system. Using three therapeutic monoclonal antibodies that bind TNFα, our results show that residues that are buried in the epitope upon antibody binding generally decrease in DEPC labeling extent. Additionally, serine, threonine, and tyrosine residues on the periphery of the epitope increase in labeling upon antibody binding because of a more hydrophobic microenvironment that is created. We also observe changes in labeling away from the epitope, indicating changes to the packing of the mTNFα homotrimer, compaction of the mTNFα trimer against the cell membrane, and/or previously uncharacterized allosteric changes upon antibody binding. Overall, DEPC-based covalent labeling mass spectrometry offers an effective means of characterizing structure and interactions of membrane proteins in living cells.

Indexed as

Membrane ProteinsTyrosineCell MembraneDiethyl PyrocarbonateHumansMass SpectrometryProtein BindingDiethyl PyrocarbonateMembrane ProteinsTyrosine

Identifiers

PMID37102678
PMCPMC10350911
OpenAlexW4367174035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.